Table 1.
Basic characteristics of research subjects.
| Characteristic | Total (34) | |
|---|---|---|
| Age, n (%) | ||
| <1 year old | 4 (11.8) | |
| 1–5 years old | 6 (16.0) | |
| >5 years old | 24 (76.0) | |
| Male, n (%) | 20 (58.8) | |
| Nutritional status, n (%) | ||
| Poor | 5 (14.7) | |
| Good | 21 (61.8) | |
| Excellent | 8 (23.5) | |
| Referral, n (%) | 33 (97) | |
| Fever, median days (IQR) | 5 (4-8) | |
| Patient clinical parameter in ER | ||
| Reactive pupils, n (%) | 34 (100) | |
| Ascites, n (%) | 32 (94.1) | |
| Hepatomegaly, n (%) | 34 (100) | |
| Gastrointestinal bleeding, n (%) | 20 (58.8) | |
| Cold extremities, n (%) | 21 (61.8) | |
| Assistive device usage, n (%) | 6 (17.6) | |
| Oxygenation, n (%) | ||
| Non-rebreathing mask | 1 (2.9) | |
| Nasal cannula | 24 (70.6) | |
| Without oxygen supplementation | 3 (8.8) | |
| CRT >2 s, n (%) | 19 (55.9) | |
| SaO2 (%), median (IQR) | 98 (97-99) | |
| Consciousness level, median (IQR) | 13 (11-15) | |
| PELOD 2 score, median (IQR) | 2 (2-11) | |
| Initial laboratory parameters within 24 h after DSS diagnosis | ||
| Hb gr/dL, median (IQR) | 14.3 (11.5–15.3) | |
| Hct %, median (IQR) | 40.9 (32.9–44.9) | |
| Leukocyte μ/L, median (IQR) | 6720 (2080–35,740) | |
| Neutrophil %, mean | 48.7 ± 10.8 | |
| Lymphocyte %, mean | 40.3 ± 13.2 | |
| Monocyte %, median (IQR) | 8.3 (5.4–11.2) | |
| NLR, median (IQR) | 1.3 (0.8–1.7) | |
| Thrombocyte μ/L, median (IQR) | 20,500 (14,000–32,000) | |
| PT seconds, median (IQR) | 17.8 (14.9–25.3) | |
| Fibrinogen mg/dL, median (IQR) | 123 (106-184) | |
| D-dimer ng/mL, median (IQR) | 832.5 (362–1119) | |
| DIC initial score, median (IQR) | 6 (4-7) | |
| Length of stay, median days (IQR) | 5 (3-7) | |
| Mortality outcome, n (%) | 9 (36.0) | |
CRT, capillary refill time; ER, emergency room; DIC, disseminated intravascular coagulation;; PELOD, pediatric logistic organ dysfunction; SaO2, arterial oxygen saturation.